Observatoire des droits humains (anglais seulement)

A new oral antiviral drug for COVID is being tested in humans – can it make a difference?

(Version anglaise seulement)

par Filipa Henderson Sousa, Postdoctoral Research Fellow in Infectious Diseases, Edinburgh Napier University
Peter Barlow, Professor of Immunology and Infection, Edinburgh Napier University

Despite the effectiveness of vaccines, we still need drugs to treat COVID. Even people who have been double vaccinated stand a small chance of getting COVID and ending up moderately or even severely ill. There are drugs to treat COVID, but they have to be given in hospital.

One promising drug that could improve things is molnupiravir, an antiviral that’s moving into the final…

Lire l'article complet